Retatrutide 20mg | Triple GLP-1 Agonist Research | MOG Research
LIMITED TIME: 15% Off All Research Peptides — Offer Expires In: 30:00
★ MOST POPULAR
Retatrutide 20mg research peptide vial (triple GLP-1 agonist) — ≥99% purity — MOG Research

Retatrutide 20mg

✓ Third-Party Tested & Verified · ≥99% Purity
$150 $130 SAVE $20

Retatrutide is a novel triple agonist peptide targeting GIP, GLP-1, and glucagon receptors. Research indicates significant metabolic activity in preclinical and clinical studies. 20mg vial, ≥99% purity, lyophilized powder.

🚚 Fast 3-5 Day Shipping 🧪 99%+ Purity Tested 🇺🇸 Shipped from USA
SELECT YOUR SUPPLY
1 Vial 1 Month Supply
$130
BEST VALUE
3 Vials 3 Month Supply · Save 15%
$390 $332
6 Vials 6 Month Supply · Save 20%
$780 $624
ADD TO CART — 1 VIAL BUY NOW

All products currently listed on this site are for research purposes ONLY. All products sold on this website are intended for research and identification purposes only. These products are not intended for human dosing, injection, or ingestion. Not for human or animal consumption.

Frequently Bought Together

🎁 FREE GIFT: Add any product below to your cart and receive a FREE Bacteriostatic Water (10ml) — a $20 value!

Retatrutide is a novel triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. This investigational compound has generated significant attention in metabolic research due to its unique tri-receptor mechanism. Each vial contains 20mg of lyophilized peptide at 99%+ purity.

Verified ≥99% purity. Every batch documented.

Each shipment includes a third-party Certificate of Analysis with HPLC purity chromatogram, ESI-MS identity confirmation, and LAL endotoxin assay. See our research peptide quality standards for the complete testing protocol. Purchasing FAQ.